Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tetanus × Lymphoid × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Lymphoma 2502 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2069 Lymphoma, Non-Hodgkin 1894 Leukemia, Lymphocytic, Chronic, B-Cell 1663 Lymphoma, Follicular 1526 Lymphoma, Large B-Cell, Diffuse 1499 Leukemia 1128 Hodgkin Disease 1081 Lymphoma, Mantle-Cell 997 Leukemia, Myeloid, Acute 797 Burkitt Lymphoma 796 Multiple Myeloma 729 Recurrence 701 Lymphoma, B-Cell, Marginal Zone 696 Lymphoma, B-Cell 615 Myelodysplastic Syndromes 564 Neoplasms 496 Lymphoma, T-Cell, Cutaneous 456 Waldenstrom Macroglobulinemia 418 Lymphoma, Large-Cell, Immunoblastic 414 Mycosis Fungoides 365 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 332 Lymphoma, Large-Cell, Anaplastic 314 Sezary Syndrome 304 Hematologic Neoplasms 295 Lymphoma, T-Cell, Peripheral 279 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 276 Myeloproliferative Disorders 263 Neoplasms, Plasma Cell 251 Blast Crisis 231

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06070961 2025-06-29

FIL_FollVax22

Fondazione Italiana Linfomi - ETS

COVID-19, Diphtheria, Herpes Zoster, Lymphoma, Lymphoma, Follicular, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡